rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1999-6-14
|
pubmed:abstractText |
Findings from previous multicenter clinical trials have suggested that tirilazad mesylate, a synthetic nonhormonal 21-aminosteroid, might be effective in preventing delayed cerebral ischemia following subarachnoid hemorrhage (SAH). This beneficial effect, however, was greater in males than females, possibly because of gender-related pharmacokinetic differences. The authors sought to assess the effects of administering a larger dose of tirilazad in women with SAH.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-3085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1011-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10350245-Dose-Response Relationship, Drug,
pubmed-meshheading:10350245-Double-Blind Method,
pubmed-meshheading:10350245-Female,
pubmed-meshheading:10350245-Humans,
pubmed-meshheading:10350245-Incidence,
pubmed-meshheading:10350245-International Cooperation,
pubmed-meshheading:10350245-Intracranial Aneurysm,
pubmed-meshheading:10350245-Ischemic Attack, Transient,
pubmed-meshheading:10350245-Middle Aged,
pubmed-meshheading:10350245-Nervous System,
pubmed-meshheading:10350245-Neuroprotective Agents,
pubmed-meshheading:10350245-Pharmaceutical Vehicles,
pubmed-meshheading:10350245-Pregnatrienes,
pubmed-meshheading:10350245-Prospective Studies,
pubmed-meshheading:10350245-Subarachnoid Hemorrhage,
pubmed-meshheading:10350245-Time Factors,
pubmed-meshheading:10350245-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
|
pubmed:affiliation |
Department of Neurological Surgery and Virginia Neurological Institute, University of Virginia, Charlottesville 22908, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|